StockData
uniQure N.V. logo

uniQure N.V. (QURE) stock

QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30208% above fair value
$19.35−0.88 (-4.35%)

Close on Nov 20, 2026Market cap $1.34BP/E –Yield –

uniQure revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

uniQure's revenue for the twelve months ending Jun 30, 2026 was $18.67M, up 30.2% year over year. For fiscal 2025 it was $16.10M, down 40.6% from the year before. Over ten years it grew 4.3% a year on average. The highest annual figure on record is $524.00M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$16.10M-40.6%
FY2024Dec 31, 2024$27.12M+71.2%
FY2023Dec 31, 2023$15.84M-85.1%
FY2022Dec 31, 2022$106.48M-79.7%
FY2021Dec 31, 2021$524.00M+1296.8%
FY2020Dec 31, 2020$37.51M+415.2%
FY2019Dec 31, 2019$7.28M-35.5%
FY2018Dec 31, 2018$11.28M-13.9%
FY2017Dec 31, 2017$13.11M-47.8%
FY2016Dec 31, 2016$25.10M+137.3%
FY2015Dec 31, 2015$10.58M+72.3%
FY2014Dec 31, 2014$6.14M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.84M+11.0%
Q1 FY2026Mar 31, 2026$3.56M+127.3%
Q4 FY2025Dec 31, 2025$5.57M+6.6%
Q3 FY2025Sep 30, 2025$3.70M+61.8%
Q2 FY2025Jun 30, 2025$5.26M-52.7%
Q1 FY2025Mar 31, 2025$1.57M-81.5%
Q4 FY2024Dec 31, 2024$5.22M-21.9%
Q3 FY2024Sep 30, 2024$2.29M+62.5%
Q2 FY2024Jun 30, 2024$11.13M+359.4%
Q1 FY2024Mar 31, 2024$8.49M+59.3%
Q4 FY2023Dec 31, 2023$6.69M-93.5%
Q3 FY2023Sep 30, 2023$1.41M-2.9%
Q2 FY2023Jun 30, 2023$2.42M+387.3%
Q1 FY2023Mar 31, 2023$5.33M+197.2%
Q4 FY2022Dec 31, 2022$102.75M+78.1%
Q3 FY2022Sep 30, 2022$1.45M-27.1%
Q2 FY2022Jun 30, 2022$497.00K-99.9%
Q1 FY2022Mar 31, 2022$1.79M+294.7%
Q4 FY2021Dec 31, 2021$57.69M+69.3%
Q3 FY2021Sep 30, 2021$1.99M+11.2%
Q2 FY2021Jun 30, 2021$463.87M+30119.4%
Q1 FY2021Mar 31, 2021$454.00K+336.5%
Q4 FY2020Dec 31, 2020$34.09M+1198.5%
Q3 FY2020Sep 30, 2020$1.79M+71.0%
Q2 FY2020Jun 30, 2020$1.54M-38.0%
Q1 FY2020Mar 31, 2020$104.00K-90.8%
Q4 FY2019Dec 31, 2019$2.63M+63.2%
Q3 FY2019Sep 30, 2019$1.05M-66.8%
Q2 FY2019Jun 30, 2019$2.47M-18.9%
Q1 FY2019Mar 31, 2019$1.14M-67.3%
Q4 FY2018Dec 31, 2018$1.61M-37.8%
Q3 FY2018Sep 30, 2018$3.15M+39.3%
Q2 FY2018Jun 30, 2018$3.05M-38.3%
Q1 FY2018Mar 31, 2018$3.48M+4.7%
Q4 FY2017Dec 31, 2017$2.58M-71.7%
Q3 FY2017Sep 30, 2017$2.26M-68.7%
Q2 FY2017Jun 30, 2017$4.94M–
Q1 FY2017Mar 31, 2017$3.32M–
Q4 FY2016Dec 31, 2016$9.13M–
Q3 FY2016Sep 30, 2016$7.22M–

More uniQure figures

See a number that looks wrong?